Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

In Finland, about 700 people are identified with diffuse large B-cell lymphoma (DLBCL) every year.

24 Feb 2022

Researchers analyze how natural killer cells respond to COVID-19

Little is understood until today on how the immune system’s natural killer (NK) cells identify which cells are infected with SARS-CoV-2.

24 Feb 2022

Recent study reveals the code involved in human gene regulation

The logic that handles gene regulation in human cells has been discovered by a team of researchers at the University of Helsinki.

24 Feb 2022

Using sound waves to turn stem cells into bone cells

Researchers have used sound waves to turn stem cells into bone cells, in a tissue engineering advance that could one day help patients regrow bone lost to cancer or degenerative disease.

23 Feb 2022

TGen collaborates with Deepcell to employ AI for analyzing single cell morphology

The Translational Genomics Research Institute, an affiliate of City of Hope, is partnering with a Silicon Valley firm to become one of the first research institutes in the world to employ a new Artificial Intelligence-powered imaging and sorting technology to classify and isolate individual diseased cells.

23 Feb 2022

Key regulator of cell differentiation discovered

Embryonic stem cells and other pluripotent cells divide rapidly and have the capacity to become nearly any cell type in the body.

22 Feb 2022

Bacteria can break down waste carbon dioxide to make valuable industrial chemicals

Bacteria are known for breaking down lactose to make yogurt and sugar to make beer. Now researchers led by Northwestern University and LanzaTech have harnessed bacteria to break down waste carbon dioxide (CO2) to make valuable industrial chemicals.

22 Feb 2022

Newly developed radio-labeled molecule may be able to pinpoint areas of inflammation

Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow a non-invasive approach to monitor inflammation in real time by positron emission tomography (PET) imaging.

22 Feb 2022

Novel platform opens new opportunities in synthetic biology

Using synthetic biology, researchers can include new functions to cells, like the ability to generate new materials or identify and answer in certain ways to diseases.

22 Feb 2022

Understanding mutational bias helps scientists predict how pathogens develop resistance to drugs

Genetic mutations help certain people succeed in the face of natural selection.

21 Feb 2022

Study develops AI-based method to help analyze protein complexes

A new technique for analyzing proteins has been developed by researchers at Martin Luther University Halle-Wittenberg (MLU) and the European Molecular Biology Laboratory in Hamburg.

21 Feb 2022

Lifelong exercise may help counteract the deterioration of fat tissue function with age

Fat tissue plays an important role in human health. However, our fat tissue loses function as we age, which can lead to type 2 diabetes, obesity, cancer and other ailments.

18 Feb 2022

Experts trigger apoptosis in leukemia cells by disrupting their energy maintenance mechanism

A group of researchers from UNIGE in Switzerland and Inserm in France has discovered a previously unknown process that could lead to the creation of novel medicines.

18 Feb 2022

CNIO researchers design new platform to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

18 Feb 2022

New study deepens the understanding of microbial sulfur metabolism

The metabolism of sulfur compounds is among the most important microbial processes sustaining life in many anoxic environments where oxygen is not present.

18 Feb 2022

Researchers discover dysregulation of transfer RNA expression in cancer

A recently published paper in the journal Molecular Cancer by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Genetics Chairman at the University of Barcelona, shows that transfer RNAs for certain amino acids are altered at the epigenetic level in some types of cancer, expressing it in an exaggerated manner in some cases and being deficient in others.

17 Feb 2022

New vaccine providing protection against future animal-to-human viral diseases may be possible

A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans -; including SARS-CoV-2, the cause of COVID-19 -; may be possible, say Johns Hopkins Medicine researchers, based on findings from their recent study.

17 Feb 2022

Novel immune deactivation pathway offers a promising therapeutic approach for cancers

Our immune systems have the potential to find and destroy cancer cells. But cancer cells can be clever and develop tricks to evade the immune system.

17 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

17 Feb 2022

New and unconventional nuclear function for oncogenic microRNA discovered

microRNAs (miRNA), non-coding RNA molecules, are widely known for regulating mRNA stability and translation. miR-10b has been increasingly implicated in the pathogenesis of gliomas, cancers of the brain.

16 Feb 2022

Cancer News and Research

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Researchers analyze how natural killer cells respond to COVID-19

Recent study reveals the code involved in human gene regulation

Using sound waves to turn stem cells into bone cells

TGen collaborates with Deepcell to employ AI for analyzing single cell morphology

Key regulator of cell differentiation discovered

Bacteria can break down waste carbon dioxide to make valuable industrial chemicals

Newly developed radio-labeled molecule may be able to pinpoint areas of inflammation

Novel platform opens new opportunities in synthetic biology

Understanding mutational bias helps scientists predict how pathogens develop resistance to drugs

Study develops AI-based method to help analyze protein complexes

Lifelong exercise may help counteract the deterioration of fat tissue function with age

Experts trigger apoptosis in leukemia cells by disrupting their energy maintenance mechanism

CNIO researchers design new platform to test drugs for possible use in brain metastases

New study deepens the understanding of microbial sulfur metabolism

Researchers discover dysregulation of transfer RNA expression in cancer

New vaccine providing protection against future animal-to-human viral diseases may be possible

Novel immune deactivation pathway offers a promising therapeutic approach for cancers

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

New and unconventional nuclear function for oncogenic microRNA discovered

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics